InsideArbitrage Event Driven Monitor – December 31, 2024
Merger Arbitrage
- VCSA: The acquisition of Vacasa, Inc. (VCSA) by Casago for $110.56 million in an all-cash transaction. As per the terms of the agreement, Casago will acquire all outstanding shares of Vacasa held by public stockholders for $5.02 per share, subject to adjustment as outlined in the merger agreement. (Press Release)
- MRNS: The acquisition of Marinus Pharmaceuticals, Inc. (MRNS) by Immedica Pharma AB, for a closing value of $151 million. Under the terms of the agreement, Immedica, through a wholly owned, direct subsidiary, will initiate a tender offer to acquire all the outstanding shares of Marinus common stock for a cash purchase price of $0.55 per share. (Press Release)
- PTVE: Pactiv Evergreen (PTVE) filed a definitive information statement. The merger is expected to be completed in mid-2025.
You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.
Only plus or premium subscribers can access this post. Subscribe today.
